Abnormal splicing of SHP-1 protein tyrosine phosphatase in human T cells: Implications for lymphomagenesis

Experimental Hematology

Volumn 31, Issue 2, 2003, Pages 131-142

  Ma, Xue Zhong ^a   Jin, Tianru ^a,b   Sakac, Darinka ^c   Fahim, Soad ^c   Zhang, Xin ^a   Katsman, Yulia ^a   Bali, Meenakshi ^a   Branch, Donald R ^a,b,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c CANADIAN BLOOD SERVICES   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; MESSENGER RNA; PROTEIN TYROSINE KINASE; RESTRICTION ENDONUCLEASE; TUMOR SUPPRESSOR PROTEIN; UNTRANSLATED RNA;

AMINO TERMINAL SEQUENCE; ARTICLE; CANCER GROWTH; CELL STRUCTURE; CONTROLLED STUDY; FRAMESHIFT MUTATION; GENE AMPLIFICATION; GENE CONSTRUCT; GENE DELETION; GENE INSERTION; GENE SEQUENCE; GENE TRANSFER; GENETIC CODE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTRON; LEUKEMIA CELL LINE; LEUKEMOGENESIS; LYMPHOMA CELL LINE; MOLECULAR CLONING; MOLECULAR WEIGHT; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SOUTHERN BLOTTING; T CELL LYMPHOMA; WILD TYPE;

EID: 0037312535     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(02)01025-1     Document Type: Article

References (40)

1. Sachs L. The control of hematopoiesis and leukemia. from basic biology to the clinic Proc Natl Acad Sci USA. 93:1996;4742-4749.
2. Marshall C.J. Tumor suppressor genes. Cell. 64:1991;313-326.
3. Bishop J.M. Molecular themes in oncogenesis. Cell. 64:1991;235-248.
4. Kinzler K.W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 87:1996;159-170.
5. Liedtke M., Pandey P., Kumar S., Kharbanda S., Kufe D. Regulation of Bcr-Abl-induced SAP kinase activity and transformation by the SHPTP1 protein tyrosine phosphatase. Oncogene. 17:1998;1889-1892.
6. Piao X., Paulson R., van der Geer P., Pawson T., Bernstein A. Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and increases degradation of the protein tyrosine phosphatase SHP-1. Proc Natl Acad Sci USA. 93:1996;14665-14669.
7. Thomas M.L. Positive and negative regulation of leukocyte activation by protein tyrosine phosphatases. Semin Immunol. 7:1995;279-288.
8. Bignon J.S., Siminovitch K.A. Identification of PTP1C mutation as the genetic defect in motheaten and viable motheaten mice. a step toward defining the roles of protein tyrosine phosphatases in the regulation of hemopoietic cell differentiation and function Clin Immunol Immunopath. 73:1994;168-179.
9. Shultz LD, Schweitzer PA, Rajan TV, et al. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell. 73:1445-1454.
10. Neel B.G. Structure and function of SH2-domain containing phosphatases. Semin Cell Biol. 4:1993;419-432.
11. D'Ambrosio D., Hippen K.L., Minskoff S.A.et al. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1. Science. 268:1995;293-297.
12. Lorenz U., Ravichandran K.S., Burakoff S.J., Neel B.G. Lack of SHPTP1 results in src-family kinase hyperactivation and thymocyte hyperresponsiveness. Proc Natl Acad Sci USA. 93:1996;9624-9629.
13. Klingmuller U., Lorenz U., Cantley L.C.et al. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell. 80:1995;729-738.
14. Yi T., Cleveland J.L., Ihle J.N. Protein tyrosine phosphatase containing SH2 domains. characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13 Mol Cell Biol. 12:1992;836-846.
15. Banville D., Stocco R., Shen S.-H. Human protein tyrosine phosphatase 1C (PTPN6) gene structure. alternate promoter usage and exon skipping generate multiple transcripts Genomics. 27:1995;165-173.
16. Nehls M., Schorpp M., Boehm T. An intragenic deletion in the human PTPN6 gene affects transcriptional activity. Hum Genet. 95:1995;713-715.
17. Martin A., Tsui H.W., Tsui F.W.L. SHP-1 variant proteins are absent in motheaten mice despite presence of splice variant transcripts with open reading frames. Mol Immunol. 36:1999;1029-1041.
18. Tsui H.W., Siminovitch K.A., de Souza L., Tsui F.W.L. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nature Genet. 4:1993;124-129.
19. Shen S.-H., Bastien L., Posner B.I., Chretien P. A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases. Nature. 352:1991;736-739.
20. Plutzky J., Neel B.G., Rosenberg R.D. Isolation of a src homology 2-containing tyrosine phosphatase. J Biol Chem. 89:1992;1123-1127.
21. Matthews R.J., Bowne D.B., Flores E., Thomas M.L. Characterization of hematopoietic intracellular protein tyrosine phosphatases. description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences Mol Cell Biol. 12:1992;2396-2405.
22. v). Exp Hematol. 17:1989;81-87.
23. Siminovitch K.A., Lamhonwah A.M., Somani A.K., Cardiff R., Mills G.B. Involvement of the SHP-1 tyrosine phosphatase in regulating B lymphocyte antigen receptor signaling, proliferation and transformation. Curr Top Microbiol Immunol. 246:1999;291-297.
24. Somani A.-K., Bignon J.S., Mills G.B., Siminovitch K.A., Branch D.R. Src kinase activity is regulated by the SHP-1 protein-tyrosine phosphatase. J Biol Chem. 272:1997;21113-21119.
25. Dong Q., Siminovitch K.A., Fialkow L., Fukushima T., Downey G.P. Negative regulation of myeloid cell proliferation and function by the SH2 domain-containing tyrosine phosphatase-1. J Immunol. 162:1999;3220-3230.
26. Beghini A., Ripamonti C.B., Peterlongo P.et al. RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia. Hum Mol Genet. 9:2000;2297-2304.
27. Bruecher-Encke B., Griffin J.D., Neel B.G., Lorenz U. Role of the tyrosine phosphatase SHP-1 in K562 cell differentiation. Leukemia. 15:2001;1424-1432.
28. Zhang Q., Raghunath P.H., Vonderheid E., Odum N., Wasik M.A. Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of SHP-1 promoter. Am J Pathol. 157:2000;1137-1146.
29. Phipps D.J., Reed-Doob P., MacFadden D.K., Piovesan J.P., Mills G.B., Branch D.R. An octapeptide analogue of HIV gp120 modulates protein tyrosine kinase activity in activated peripheral blood T lymphocytes. Clin Exp Immunol. 100:1995;412-418.
30. Branch D.R., Mills G.B. pp60c-src expression is induced by activation of normal human T lymphocytes. J Immunol. 154:1995;3678-3685.
31. Ausubel FM, Brent R, Kingston RE, et al. Analysis of DNA sequences by blotting and hybridization. In: Brown TA, ed. Current Protocols in Molecular Biology, Volume 1. Boston: Massachusetts General Hospital and Harvard Medical School Press, 1993. p. 2.9.1-2.10.16.
32. Mosmann T. Rapid colorimetric assay for cellular growth and survival. application to proliferation and cytotoxicity assays J Immunol Methods. 65:1983;55-63.
33. Branch D.R., Guilbert L.J. Practical in vitro assay systems for the measurement of hematopoietic growth factors. J Tissue Cult Methods. 10:1986;101-108.
34. Sathish J.G., Johnson K.G., LeRoy F.G.et al. Requirement for CD28 co-stimulation is lower in SHP-1-deficient T cells. Eur J Immunol. 31:2001;3649-3658.
35. Goldman F.D., Ballas Z.K., Schutte B.C.et al. Defective expression of p56lck in an infant with severe combined immunodeficiency. J Clin Invest. 102:1998;421-429.
36. Nervi S., Atlan-Gepner C., Kahn-Perles B.et al. Specific deficiency of p56lck expression in T lymphocytes from type 1 diabetic patients. J Immunol. 165:2000;5874-5883.
37. Pei D., Lorenz U., Klingmuller U.et al. Intramolecular regulation of protein tyrosine phosphatase SH-PTP1. a new function for Src homology 2 domains Biochemistry. 33:1994;15483-15493.
38. Yang J., Cheng Z., Niu T., Liang X., Zhao Z.J., Zhou G.W. Structural basis for substrate specificity of protein-tyrosine phosphatase SHP-1. J Biol Chem. 275:2000;4066-4071.
39. Mills G.B., Schmandt R., Gibson S.et al. Transmembrane signaling by the interleukin-2 receptor. progress and conundrums Sem Immunol. 5:1993;3458-3641.
40. Neel H., Gondran P., Weil D., Dautry F. Regulation of pre-mRNA processing by src. Curr Biol. 5:1995;413-422.